InsiderClue
← All stocks

Drugs Made In America Acquisition II Corp.

DMII Balanced
CIK 0002040475 #2895 in the set updated 17 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
2 of 2 sales
Net
$0.00
$0.00 against sales at will

By person

6 insiders · 4 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Drugs Made In America Acquisition II LLC entity
10% owner
— (1)
— (1)
$0.00
6,708,333
10.53%
—
−53.3%
Stockwell Lynn
CEO and Exe. Chair of Board
— (1)
— (1)
$0.00
6,708,333
10.53%
—
−53.3%
Do Catherine
Director
—
—
—
100,000
0.1570%
—
—
Shulgan Myron W.
Director
—
—
—
100,000
0.1570%
—
—
Worman Glenn C.
CFO
—
—
—
100,000
0.1570%
—
—
Prasad Sridhar G.
Director
—
—
—
100,000
0.1570%
—
—

Individual transactions

4
Insider
Date
Role
Action
Shares
Price
Amount
Drugs Made In America Acquisition II LLC
26 Sep 2025
10% owner
Sell
7,966,667
—
no price
Drugs Made In America Acquisition II LLC
26 Sep 2025
10% owner
Buy
700,000
—
no price
Stockwell Lynn
26 Sep 2025
CEO and Exe. Chair of Board
Sell indirect
7,966,667
—
no price
Stockwell Lynn
26 Sep 2025
CEO and Exe. Chair of Board
Buy indirect
700,000
—
no price

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 4
Shares from compensation/vesting 1,200,000
History held since 1 Oct 2025